In this case, the patient does not have features fully consistent with a diagnosis of Crohn's disease. The presentation is more in keeping with a diagnosis of ileitis of spondylarthropathy. It can ...

A diagnostic delay of 2 to 6 years may be typical in axSpA, noted Raj Sengupta, MBBS, of the University of Bath in England, ...

Background: TNFα blockers have been shown to be highly efficacious in patients with active ankylosing spondylitis (AS). Objective: To identify parameters predicting the clinical response to TNF ...

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...

治疗初期，需按足量、足疗程使用生物制剂。确保足够的药物浓度能够充分发挥药效，达到最大程度的病情缓解。切忌断断续续使用，这会导致病情无法有效控制，难以实现减药目标。

COVID-19 is associated with long-term risk for autoimmune and autoinflammatory connective tissue disorders, according to a ...

For patients with axial spondyloarthritis (axSpA) who do not benefit from or cannot take nonsteroidal anti-inflammatory drugs ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...

Doctors weigh in on why patients often receive conflicting diagnoses, and share insights on navigating the complex path to clarity and trust.

The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...